Can ovarian cancer metastasize to the lungs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metastasis of Ovarian Cancer to the Lungs

Yes, ovarian cancer can metastasize to the lungs, which is one of the common sites of distant metastasis in advanced disease. Lung metastasis represents a significant progression of ovarian cancer and impacts both prognosis and treatment planning.

Patterns of Ovarian Cancer Metastasis

Ovarian cancer has a distinct pattern of spread that differs from many other malignancies:

  • Primary spread occurs within the peritoneal cavity through direct extension and peritoneal fluid circulation 1
  • Distant metastases (stage IV disease) develop in approximately one-third of ovarian cancer patients 2
  • Common sites of distant metastasis include:
    • Liver (most common)
    • Pleura
    • Lungs
    • Central nervous system
    • Skin
    • Extra-abdominal lymph nodes 2

Lung Metastasis in Ovarian Cancer

Lung involvement occurs in several patterns:

  • Parenchymal metastases (nodules within lung tissue)
  • Pleural effusions (more common than parenchymal disease)
  • Lymphangitic spread
  • Endobronchial metastases (rare but documented) 3

According to a comprehensive study on distant metastases in ovarian cancer, lung metastases were found in 8 out of 67 metastatic sites (approximately 12% of all distant metastases) 2.

Clinical Presentation of Lung Metastases

When ovarian cancer metastasizes to the lungs, patients may present with:

  • Respiratory symptoms (cough, dyspnea)
  • Pleural effusions
  • Hemoptysis (particularly with endobronchial involvement)
  • Often asymptomatic and discovered on imaging 3

Risk Factors for Developing Distant Metastases

Several factors increase the risk of developing distant metastases, including lung metastases:

  • Advanced stage at initial diagnosis
  • High-grade tumors
  • Lymph node involvement at diagnosis 2

Diagnosis of Lung Metastases

Diagnosis typically involves:

  • Chest imaging (CT scan)
  • Pleural fluid cytology when effusion is present
  • Bronchoscopy with biopsy for endobronchial lesions
  • Immunohistochemical staining to confirm ovarian origin (cytokeratin patterns) 4

Prognosis

The development of distant metastases, including lung metastases, significantly impacts prognosis:

  • Median survival from diagnosis of distant metastasis is approximately 12 months 2
  • The interval between initial ovarian cancer diagnosis and development of distant metastasis is a significant prognostic factor (longer interval correlates with better prognosis) 2

Clinical Implications

The presence of lung metastases from ovarian cancer:

  • Indicates stage IV disease
  • Requires systemic therapy approaches
  • May benefit from multidisciplinary management including medical oncology, pulmonology, and thoracic surgery in selected cases

While ovarian cancer primarily spreads within the peritoneal cavity, clinicians should remain vigilant for pulmonary manifestations, as they represent a significant site of distant metastasis that impacts both treatment planning and prognosis.

References

Research

Ovarian cancer development and metastasis.

The American journal of pathology, 2010

Research

Distant metastases in ovarian carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2003

Research

Lung Parenchymal and Endobronchial Metastases From Ovarian Carcinoma.

Journal of bronchology & interventional pulmonology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.